| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3694418
Max Phase: Preclinical
Molecular Formula: C18H17BClFN2O5
Molecular Weight: 406.61
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(C)OCCOc1nc(Oc2cc(F)c3c(c2)COB3O)c(Cl)cc1C#N
Standard InChI: InChI=1S/C18H17BClFN2O5/c1-10(2)25-3-4-26-17-11(8-22)6-14(20)18(23-17)28-13-5-12-9-27-19(24)16(12)15(21)7-13/h5-7,10,24H,3-4,9H2,1-2H3
Standard InChI Key: UPBKTTZHNZAEQA-UHFFFAOYSA-N
Associated Targets(Human)
Phosphodiesterase 4A 1943 Activities
Phosphodiesterase 4B 2748 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 406.61 | Molecular Weight (Monoisotopic): 406.0903 | AlogP: | #Rotatable Bonds: |
| Polar Surface Area: | Molecular Species: | HBA: | HBD: |
| #RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
| Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
References
| 1. (2014) Boron-containing small molecules, |
| 2. (2016) Boron containing small molecules, |
Source
Source(1):